2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm: Machine learning classifiers and subjective vocal perception of Parkinson’s disease patients and healthy control

Y. Manor, S. Naor, D. Shpunt, N. Diamant, A. Hillel, A. Ezra, I. Opher, Y. Hauptman, R. Aloni-Lavi, A. Faust-Socher, H. Shabtai, R. Peled, A. Migirov, T. Gurevich (Tel Aviv, Israel)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Management of poor response to Botulinum toxin in cervical dystonia: a multicentre audit

H. Tucker, F. Osei-Poku, D. Ashton, R. Lally, J. Alty, C. Kobylecki (Salford, United Kingdom)

Dystonia · Les Muses Terrace, Level 3

1:45pm-3:15pm: MDS Translation Program for MDS-UPDRS and UDysRS

S. Luo, N. Lapelle, P. Martin, C. Goetz, G. Stebbins (Durham, NC, USA)

Rating Scales · Les Muses Terrace, Level 3

1:45pm-3:15pm: MDS-UPDRS Part III predictors of Part II Item Scores in PPMI

J. Cedarbaum, Z. Xiao, M. Yang (Cambridge, MA, USA)

Rating Scales · Les Muses Terrace, Level 3

1:45pm-3:15pm: Measuring perceived-health status in Parkinson’s Disease – the role of London Handicap Scale

D. Silva, M. Coelho, T. Soares, T. Vale, L. Guedes, R. Maciel, A. Antunes, S. Camargos, A. Valadas, C. Godinho, D. Maia, P. Lobo, R. Maia, T. Teodoro, C. Rieder, A. Velon, M. Rosas, A. Calado, V. Caniça, F. Cardoso, J. Ferreira (Lisbon, Portugal)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Measuring progression of nigrostriatal degeneration in Parkinson’s disease using 18F-AV-133 vesicular monoamine transporter type-2 (VMAT2) PET

S. Xu, V. Dore, P. Alexander, Y. Lie, S. Bozinovski, R. Mulligan, K. Young, V. Villemagne, C. Rowe (Melbourne, Australia)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Medical and Device-Guided Therapies and Deep Brain Stimulation in Parkinson’s disease: Experience of a Tertiary Centre from Turkey

Y. Sucullu Karadag, D. Divanlıoglu, E. Kocabicak, N. Subutay Oztekin, D. Belen (Ankara, Turkey)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Medical management after subthalamic nucleus deep brain stimulation in patients with Parkinson’s Disease

A. Bertholo, R. Cury (São Paulo, Brazil)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Memantine and 3D gait analysis in patient with Parkinson’s disease: an observer-blind randomized clinical trial

I. Miliukhina, E. Gracheva (Saint-Petersburg, Russian Federation)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Memory enhancing effect of Combined Alcoholic Extract of Cedrus deodara Loud. and Vitex Nirgundi in scopolamine-induced cognitive impairment in mice

A. Jain, S. Jain (Sagar, India)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3